Company: PSTV
Filing Date: 2025-03-14
Form Type: PRE 14A
Source: 0001140361-25-008857
Chunk: 37

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-14
Form: PRE 14A
Chunk 37
---
                                                   |     |    48,921 |     |      40,012 |     |       88,933 |     | *         |
| Robert P. Lenk, PhD(13)                                             |     |    29,327 |     |      23,836 |     |       53,163 |     | *         |
| All current executive officers and directors as a group (8 persons) |     |   146,173 |     |     320,942 |     |      467,115 |     | 3.76%     |

| * | Less than 1%. |

| (1) | Unless otherwise indicated, the address of each of the persons listed above is c/o Plus Therapeutics, Inc., 2710 Reed Rd, Suite 160, Houston, TX 77051. |

| (2) | Shares of Common Stock subject to stock options or warrants currently exercisable or exercisable within 60 days of March 4, 2025 are deemed to be outstanding for purposes of computing the percent ownership of the person holding such options or warrants and the percent ownership of any group of which the holder is a member but are not deemed outstanding for purposes of computing the percentage of any other person or group. |

| (3) | Reflects beneficial ownership of Common Stock as defined in Rule 13d-3 of the Exchange Act. |

23

TABLE OF CONTENTS

| (4) | Reflects (i) AIGH Investment Partners, L.P. (“AIGH LP”) holdings of: (A) 437,265 shares of Common Stock, (B) 1,655,305 shares of Common Stock issuable upon the exercise of Prefunded Warrants, (C) 1,655,305 shares of Common Stock issuable upon the exercise of Series A Warrants, (D) 1,655,305 shares of Common Stock issuable upon the exercise of Series B Warrants, and (E) 1,103,537 shares of Common Stock issuable upon the exercise of May 2024 Warrants; (ii) WVP Emerging Manager Onshore Fund, LLC – AIGH Series (“Onshore – AIGH”) holdings of: (A) 570,216 shares of Common Stock issuable upon the exercise of Prefunded Warrants, (B) 570,216 shares of Common Stock issuable upon the exercise the Series A Warrants, (C) 570,216 shares of Common